Legal highs/New Psychoactive Substances testing
LGC has been awarded a further extension to our IS017025 accreditation from the United Kingdom Accreditation Service (UKAS), to test for psychoactive substances and related compounds, otherwise known as legal highs or New Psychoactive Substances (NPS). This extension provides further evidence of the quality associated with LGC’s testing service and also expands the drug and alcohol testing programme.
What are legal highs or new psychoactive substances?
NPS are substances that are used like illegal drugs, such as, cocaine or cannabis, for recreational purposes and are either covered by the 1971 Misuse of Drugs Act or by the Psychoactive Substances Act 2016.
NPS screening and confirmation service
Screening and confirmation service to detect the use of new compounds
The majority of Psychoactive Substances are not detectable using traditional workplace drug testing panels. LGC utilise the latest state of the art mass spectrometry techniques to offer a broad coverage, sensitive and most importantly ‘current’ screening and confirmation service to detect the use of these new compounds which includes, piperazines, cathinones, tryptamines, phenethylamines and synthetic cannabinoids, as well as many others.
Issues from using new psychoactive substances?
The NHS has seen an increase in health and other problems caused by regular use of NPS affecting users' employment, education and even imprisonment. Whilst these drugs are marketed heavily and sold over the internet it doesn’t mean that they are safe or approved for people to use.
Serious and on-going health issues arise in a large group of users affecting behaviours and safety. Side effects of NPS have included severe agitation, paranoia, high blood pressure, increased heart rate and heightened aggression.
LGC offer tests on a number of psychoactive substances for the public and private sector to see the full list of the substances we test, please download a copy of our new psychoactive substances fact sheet or contact us for further information.